← back to search

Qihong Huang

Fudan University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include MicroRNA in disease regulation, Cancer-related molecular mechanisms research, RNA modifications and cancer, and CRISPR and Genetic Engineering.
h-index
53
citations
12,212
works
255
NIH funding
primary concept
email

Recent publications

Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled Trial
Journal of Clinical Oncology 2024cited by 24position: middledoi
Adavosertib and beyond: Biomarkers, drug combination and toxicity of WEE1 inhibitors
Critical Reviews in Oncology/Hematology 2023cited by 28position: middledoi
Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-Cas
Molecular Cell 2020cited by 63position: middledoi
Significance of clinical phenomes of patients with COVID‐19 infection: A learning from 3795 patients in 80 reports
Clinical and Translational Medicine 2020cited by 37position: middledoi
A Smart DNA Tweezer for Detection of Human Telomerase Activity
Analytical Chemistry 2018cited by 83position: middledoi
RNA-binding protein LIN28B inhibits apoptosis through regulation of the AKT2/FOXO3A/BIM axis in ovarian cancer cells
Signal Transduction and Targeted Therapy 2018cited by 66position: middledoi
Decreased macrophage inflammatory protein (MIP)‐1α and MIP‐1β increase the risk of developing nasopharyngeal carcinoma
Cancer Communications 2018cited by 29position: middledoi
Quantification of familial risk of nasopharyngeal carcinoma in a high‐incidence area
Cancer 2017cited by 76position: middledoi
Long non-coding RNAs in metastasis
Cancer and Metastasis Reviews 2017cited by 70position: firstdoi
Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer
Clinical Cancer Research 2016cited by 125position: middledoi
Suppression of MicroRNA 200 Family Expression by Oncogenic KRAS Activation Promotes Cell Survival and Epithelial-Mesenchymal Transition in KRAS-Driven Cancer
Molecular and Cellular Biology 2016cited by 86position: middledoi
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers
Cancer Cell 2015cited by 676position: middledoi
Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p–MFF axis
Oncotarget 2015cited by 52position: middledoi
A Functional Genomic Approach Identifies FAL1 as an Oncogenic Long Noncoding RNA that Associates with BMI1 and Represses p21 Expression in Cancer
Cancer Cell 2014cited by 378position: middledoi
Evaluation of plasma Epstein‐Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high‐risk populations in Southern China
Cancer 2014cited by 90position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Su‐Mei Cao · Sun Yat-sen University4 papers (2014–2024)Shang‐Hang Xie · Sun Yat-sen University4 papers (2014–2024)Zhiwei Liu · Tianjin University of Science and Technology3 papers (2014–2024)János L. Tanyi · The Ohio State University3 papers (2014–2018)Kathleen T. Montone · The Ohio State University3 papers (2014–2018)Yi‐Xin Zeng · Sun Yat-sen University3 papers (2014–2024)Xiaomin Zhong · University of Science and Technology of China3 papers (2014–2018)Mingfang Ji · First Affiliated Hospital Zhejiang University2 papers (2014–2024)Jianfeng Shen · Shanghai University2 papers (2016–2018)Hui‐Lan Rao · Sun Yat-sen University2 papers (2014–2024)Dongmei Zhang · Heilongjiang Academy of Sciences2 papers (2014–2016)Xiaojun Chen · Putian University2 papers (2016–2018)Weimin Ye · Fujian Medical University2 papers (2014–2017)Xiang Guo · Qingdao University2 papers (2014–2024)Xinhong He · Shanghai Medical College of Fudan University2 papers (2016–2018)Thomas L. Vaughan · Fred Hutch Cancer Center1 papers (2017–2017) · 1 papers (2020–2020)Guangwu Huang · Guangxi University1 papers (2017–2017)Gordon B. Mills · Massachusetts General Hospital1 papers (2014–2014)Weimin Yao · Wenzhou Medical University1 papers (2016–2016)